FT Adviser Vantage PointJan 2 2025

What Trump’s victory means for biotech investors

twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by
What Trump’s victory means for biotech investors
© Pexels
comment-speech

While most US equities rallied sharply in the aftermath of Donald Trump’s win in the US election, the narrative around biotech stocks has been drastically different, according to Woody Stileman, managing director of RTW Investments, manager of RTW Biotech Opportunities investment trust.

Unlimited access to our award-winning journalism

Read the full story with a free account

  • Read without interruption - full access to our reporting on the financial intermediary market
  • Bank CPD while you read
  • Share your perspectives
  • Stay in the know with our daily newsletter
  • Receive personal recommendations
Already have an account?Sign In

Related articles

Related Topics

Investment trusts
A service from the Financial Times